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Abstract We purified Saccharomyces cerevisiae RNase H(70)
to homogeneity, using an optimized chromatographic purification
procedure. Renaturation gel assay assigned RNase H activity to
a 70 kDa polypeptide. Sequencing of tryptic peptides identified
the open reading frame YGR276c on chromosome VII of the S.
cerevisiae genome as the corresponding gene, which encodes a
putative polypeptide of molecular mass of 62 849. We therefore
renamed this gene RNH70. Immunofluorescence microscopy
using a RNH70-EGFP fusion construct indicates nuclear
localization of RNase H(70). Deletion of RNH70 from the yeast
genome did not result in any serious phenotype under the
conditions tested. Homology searches revealed striking similarity
with a number of eukaryotic proteins and open reading frames,
among them the chimpanzee GOR protein, a homolog of a
human autoimmune antigen, found to elicit autoimmune response
in patients infected with hepatitis C virus.
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1. Introduction
According to current knowledge RNA-DNA hybrids occur
transiently in living cells, necessarily during DNA replication
and transcription, and during the probably very rare events of
retrotransposition. Whereas no special mechanism for dealing
with the short hybrids arising during regular transcription is
known, RNA primers of Okazaki fragments ^ which are in-
termediates of lagging strand DNA synthesis and are hy-
bridized to the DNA template strand ^ have to be removed
enzymatically [1]. Enzymes hydrolyzing speci¢cally the RNA
strand of RNA-DNA hybrids, called ribonucleases H
(RNases H), were found in all organisms yet examined [2].
Nevertheless, the most intensively studied and best under-
stood proteins exhibiting RNase H activity are retroviral re-
verse transcriptases [3]. Their RNase H activity catalyzes an
essential step in the life cycle of retroviruses, i.e. the destruc-
tion of the RNA genomes after their retrotranscription into
DNA. Another well studied RNase H is RNase HI of Esche-
richia coli, which is evolutionarily related to the RNase H
domain of reverse transcriptases [4]. Interestingly, this enzyme
was found to play a regulatory role during DNA replication:
in wild type cells it seems to be on the watch for super£uous
RNA-DNA hybrids which might have arisen from discontin-
ued transcripts (for review see [5]). In E. coli, RNA primers of
Okazaki fragments are removed by the RNase H activity of
DNA polymerase I [1]. Nevertheless, still another enzyme with
RNase H activity exists in E. coli, RNase HII [6], the primary
structure of which is not related to the RNase H domain of
reverse transcriptases, and the physiological role of which is as
yet unknown. Remarkably, open reading frames, character-
ized by their sequences them as orthologs of E. coli RNase
HII, were found in all bacterial genomes examined. Genes
encoding orthologs of the two bacterial proteins were recently
cloned from eukaryotic organisms, e.g. from the budding
yeast Saccharomyces cerevisiae [7,8], from the fruit £y Droso-
phila melanogaster [9] and from human cells [10^13].
S. cerevisiae RNase H1 is structurally related to E. coli
RNase HI [7] ; the biological role of that enzyme, however,
is as yet unknown. The yeast protein representing the evolu-
tionary relative of bacterial RNase HII was, on the basis of its
molecular weight, called RNase H(35) by us [8]. It is probably
the main RNase H of that organism because deletion of the
respective gene causes a drastic reduction of RNase H activity
in yeast cell extracts [8]. Surprisingly, when RNase H activity
originally was enriched by then classical puri¢cation steps
from yeast cell extracts, an enzyme of molecular weight
around 70 kDa was found and called RNase H(70) [14]. Fol-
lowing studies intended to isolate the gene encoding RNase
H(70) revealed that the original preparation contained copuri-
¢ed proteins, the most prominent of which was poly(A) bind-
ing protein (PABP [15]) possessing a very similar molecular
weight.
In this communication we report an improved puri¢cation
procedure for RNase H(70), which removed PABP as well as
a having reverse transcriptase activity which earlier was con-
sidered a property of RNase H(70) [16]. The new procedure
resulted in a small amount of homogeneous protein which
could be used for sequencing of several tryptic peptides which
¢nally paved the way for the identi¢cation of the gene,
RNH70.
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2. Materials and methods
2.1. Yeast strains and growth media
Strains MZ3 (MatK ; pep4-3 trp1 leu2-v1 ura3-v1) and MZ3vPABP
(derived from MZ3 by deleting a 405 bp SpeI/SphI fragment from the
C-terminus of the PABP gene and introducing the URA3 marker [17])
were used for enzyme puri¢cation. Strain K699 (Mata ura3 ade 2-1
trp1-1 can1-100 leu2-3,112 his3-11,15 ssdl [8]) was used for construct-
ing strain BC70 (Mata ura3 ade 2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ssdl rnh70v : :URA3); strain AK606 (Mata ura3 leu2 trp1 his3),
an adenine-prototrophic meiotic segregant from a cross between
strains K699 and MZ3, was employed for transformation with plas-
mid pUG36-RNH70. YPD growth medium (1% yeast extract, 2%
peptone, 2% dextrose) and synthetic complete medium (SC) were as
described [18].
2.2. Enzyme activity assays, standard techniques for protein analysis,
materials and enzymes
The standard RNase H assay in solution was performed as de-
scribed [14], and the reverse transcriptase assay was performed as
reported earlier [16]. The renaturation gel assay for the in situ detec-
tion of RNase H activity was performed according to Frank et al. [19]
using Mn2 as a divalent cation. Protein concentration was deter-
mined by the method of Bradford [20]. Discontinuous SDS-PAGE
was performed according to Laemmli [21]; protein bands were visual-
ized with Coomassie brilliant blue G250 or by silver staining [22]. [K-
32P]ATP, 3000 Ci/mmol, 10 mCi/ml and [5-3H]uridine 5P-triphosphate,
15.6 Ci/mmol, 1 mCi/ml, were from American Radiolabeled Chem-
icals (ARC). DNA cellulose was prepared according to [23]. Oli-
go(dT), RNA polymerase (E. coli), phenyl-Sepharose, and Mono P
for chromatofocusing were purchased from Pharmacia-LKB. Hydrox-
yapatite and A⁄-Gel Blue were from Bio-Rad. Restriction enzymes,
antipain, pepstatin A and PCR-related products were from Boeh-
ringer Mannheim. PMSF, TPCK and TLCK were purchased from
Fluka.
2.3. Puri¢cation of RNase H(70)
To minimize proteolysis, all puri¢cation steps were carried out at
4‡C, and protease inhibitors (0.2 mM PMSF and 1 mM sodium sul-
¢te, pH 8.0; 0.1 mM sodium tetrathionate; 1 WM each of TLCK,
TPCK, pepstatin A, and antipain) and 0.1% L-mercaptoethanol
were included in all bu¡ers. After having used strain MZ3vPABP
for working out a puri¢cation procedure by which RNase H activity
could unambiguously be separated from PABP the following large-
scale preparation was carried out (see Fig. 1A). Cells (strain MZ3)
were grown in a 4 l fermenter as a continuous culture at pH 6.2 and
30‡C using YPD as a medium, and starting with a cell density of
1.6U106/ml. The cells were harvested by centrifugation, washed
once with bu¡er A (20 mM Tris-HCl pH 7.9, 1 mM EDTA, 10%
glycerol) containing 2 M NaCl, and frozen in liquid nitrogen. The
cell pellet (120 g wet weight per frozen aliquot) was resuspended in
180 ml of bu¡er A containing 2 M NaCl, and after addition of an
equal volume of acid washed glass beads (diameter 0.45 mm), the
suspension was homogenized and separated from glass beads, undis-
rupted cells and cell fragments as described [14]. The cell extract was
subsequently centrifuged for 120 min at 43 000 rpm in a Beckman 45
Ti rotor and ¢ltered through a paper ¢lter. To remove nucleic acids,
the supernatant was treated with polyethylene glycol 6000 (PEG, 10%
w/v ¢nal concentration) for 30 min on ice followed by centrifugation
for 35 min at 22 000 rpm (Beckman 45 Ti rotor). After dialysis of the
supernatant against bu¡er A containing 0.1 M NaCl (2U2 h) and
centrifugation for 25 min at 24 000 rpm (Beckman 45 Ti rotor), the
clear supernatant was loaded on a 360 ml DNA cellulose column
(£ow rate 60 ml/h). After extensive washing (until no protein was
detectable in the £ow-through), the bound protein was completely
eluted with bu¡er A containing 2 M NaCl. Protein containing frac-
tions (10 ml each) were analyzed for RNase H activity and pooled.
The pool was adjusted with ammonium sulfate up to 60% saturation
and, after 20 h of storage, centrifuged (35 000 rpm; 45 min; 45 Ti
rotor). The precipitated proteins were dissolved in bu¡er A containing
1 M ammonium sulfate and loaded onto a 100 ml phenyl-Sepharose
column (£ow rate 30 ml/h). After washing, protein was eluted with
500 ml of a decreasing gradient (1^0 M ammonium sulfate in bu¡er
A). In the fractions PABP was detected with the aid of a rabbit
antiserum raised against the protein expressed in and puri¢ed from
E. coli [17], and reverse transcriptase by determination of enzyme
activity. Both proteins eluted in fractions well separated from those
containing RNase H activity. The latter (6 ml each) were pooled,
precipitated with ammonium sulfate (60% saturation) and centrifuged
(35 000 rpm; 45 min; 45 Ti rotor). The precipitated protein was dis-
solved in 40 ml bu¡er K1 (25 mM K2HPO4/KH2PO4, pH 6.8, 10%
glycerol), dialyzed against bu¡er K1 (2U2 h) and loaded onto a 40 ml
hydroxyapatite column (£ow rate 24 ml/h). After washing, the bound
protein was eluted with a linear increasing phosphate gradient of
300 ml (25^500 mM K2HPO4/KH2PO4, pH 6.8, 10% glycerol). RNase
H containing fractions (6 ml each) were pooled. The pool was dia-
lyzed two times against bu¡er K2 (10 mM K2HPO4/KH2PO4, pH 6.8,
5 mM MgCl2, 10% glycerol) and loaded onto a 40 ml A⁄-Gel Blue
column (£ow rate 30 ml/h). After washing, the elution took place
using a 300 ml linear increasing gradient (0^2 M NaCl in bu¡er
K2). RNase H containing fractions (6 ml each) were pooled. The
pool was desalted with a PD10 column (Pharmacia) and applied to
a Mono P column (5U200 mm), which was equilibrated with 25 mM
BisTris-HCl, pH 7.1, 10% glycerol, PMSF and L-mercaptoethanol.
Elution was done with Polybu¡er 74 (Pharmacia), pH 4.0, 10% glyc-
erol, PMSF and L-mercaptoethanol. Fractions (1 ml each) were col-
lected and analyzed for the presence of RNase H using the renatura-
tion gel assay [19].
2.4. Peptide sequencing
The RNase H(70) preparation was separated on a preparative 12%
SDS-PAGE, stained with Coomassie brilliant blue R-250 (Serva) and
the band corresponding to the RNase H(70) protein was cut out and
concentrated on a specially designed concentration gel according to
Vandekerckhove et al. [24]. Approximately 5 Wg of the puri¢ed and
concentrated RNase H(70) polypeptide was blotted from the Vande-
kerckhove gel onto a poly(vinylidene di£uoride) (PVDF) membrane
(Millipore, Bedford, MA, USA) using a standard blotting tank sys-
tem. The transfer bu¡er contained 13 mM sodium carbonate pH 9.9
and 20% methanol. The protein spot was detected by staining with
Coomassie brilliant blue R-250 and afterwards excised from the mem-
brane. The blotted protein sample was digested with sequencing grade
trypsin (Promega, Madison, WI, USA) as described by Fernandez et
al. [25], except that the detergent Triton X-100 was replaced by octyl-
L-D-glucopyranoside (Boehringer Mannheim, Germany). Peptide
mapping was carried out on a 1U250 mm Vydac C18 column at
40‡C with a £ow rate of 50 Wl/min using the HP 1100 HPLC system
(Hewlett-Packard, Waldbronn, Germany). Selected peptide fractions
were analyzed by automated Edman degradation using the HP
G1005A protein sequencing system (Hewlett-Packard, Palo Alto,
CA, USA). Three peptide sequences, TSVQEDDHT, NTFNEISD,
and CVEDDET, were detected in ORF YGR276c on chromosome
VII of the S. cerevisiae genome. YGR276c was renamed RNH70 and
cloned.
2.5. PCR ampli¢cation and cloning procedures
In order to amplify the RNase H(70) coding sequence for the pro-
duction of a deletion allele of the RNH70 gene, PCRs were performed
with yeast genomic DNA (Promega) as template. The following prim-
ers were used for PCR with the Expand PCR system (Boehringer
Mannheim) for generating a 2273 bp fragment to be cloned into
pUC18: forward primer rh70d3/EcoRI: 5P-TGTGACTGAATTC-
TAATGTACTTGGAGGAAGGGAGGAAGACG-3P and reverse
primer rh70d4/HindIII: 5P-CGGATGTAAGCTTTCTACAGAGG-
GAGAGCTGTGAGGATATATT-3P. A PCR product of the ex-
pected size was obtained, digested with EcoRI and HindIII, gel puri-
¢ed and ligated into EcoRI/HindIII digested pUC18 vector. A SspBI/
SmaI fragment of 1549 bp, including nearly the complete ORF, was
replaced by a 1125 bp fragment carrying the URA3 gene. The isolated
and gel puri¢ed deletion allele was used for integrative transformation
[26], and Ura transformants were isolated. They were checked by
speci¢c PCR for successful gene replacement and analyzed for phe-
notypes. One of the mutants, BC70, was used for further experiments.
2.6. Cellular localization of yeast RNase H(70) enhanced green
£uorescent protein fusion
Primers RH70/EcoRI and RH70/SalIrev2 were used to introduce
EcoRI and SalI restriction sites at the beginning and end of the
RNase H(70) coding sequence, respectively; RH70/EcoRI: 5P-G-
ATGTCGGAATTCATGCAAGTAGAAGGGCCTGACACTAA-3P ;
RH70/SalIrev2: 5P-GATGTCGTCGACTATAGTCCTTTGAATTG-
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GCACCTTCAT-3P. The ampli¢ed fragment of RNH70 was inserted
into the pUG36 vector (U. Gu«ldener and J. Hegemann, manuscript in
preparation). This system allowed the expression of RNH70 fused to
the carboxy-terminus of the enhanced green £uorescent protein
(EGFP) under the control of the yeast MET25 promoter. The strain
AK606 was transformed with the resulting pUG36-RNH70 vector,
grown in SC medium lacking uracil and induced by addition of me-
thionine for 4 h. Formaldehyde ¢xed and DAPI stained cells were
viewed with a Nikon FXA microscope (EX450^490 nm), and photo-
graphed on Fujichrome 400 ¢lm.
3. Results
3.1. Puri¢cation of RNase H(70)
When puri¢cation of RNase H activity from yeast cells was
originally attempted in our laboratory we ended up with a
protein fraction which showed in SDS-PAGE one prominent
band around 70 kDa, and by glycerol gradient centrifugation
an activity peak at a sedimentation value corresponding to the
same molecular weight [14]. Further studies, however, re-
vealed the presence of PABP (molecular mass 64 344) and of
a reverse transcriptase activity. As PABP at that time was just
known to be somehow involved in transcription termination it
would have been reasonable that it possessed the RNase H
activity. To ¢nd out whether this was the case or whether
PABP represented a separate but copuri¢ed protein, a strain,
MZ3vPABP, containing a PABP gene with a shortened C-
terminus and thus a PAB protein of molecular mass di¡erent
from that of RNase H(70), namely 55 429, was constructed,
and an antiserum was raised against E. coli expressed PABP.
As described in detail elsewhere [17] these experimental means
¢nally enabled us to unambiguously identify PABP as an
impurity of the RNase H preparation. By initially using strain
MZ3vPABP for puri¢cation we con¢rmed the existence of a
separate RNase H molecule exhibiting in SDS-PAGE a mo-
lecular weight around 70 kDa, for which therefore the name
RNase H(70) was retained.
The newly worked out puri¢cation procedure, indicated in
Fig. 1A, and described in detail in Section 2, allows separation
of PABP as well as of the reverse transcriptase activity from
RNase H(70) by using a hydrophobic interaction chromatog-
raphy (HIC) on phenyl-Sepharose as second chromatographic
step. A further improvement compared to the original proce-
dure is achieved by the employment of A⁄-Gel Blue chroma-
tography and chromatofocusing on a Mono P column (Table
1). Even when starting with 120 g of yeast cells (wet weight)
the amount of protein after this last chromatography was very
low and an overall puri¢cation factor could not be deter-
mined. Analysis of the fractions from the Mono P column
by separation of proteins on SDS-PAGE and silver staining
(Fig. 1B) revealed a prominent band around 70 kDa in the
same fractions which exhibited RNase H activity in the in situ
renaturation gel assay (see Fig. 1B). Fraction 6 from the
Mono P column was further processed for isolation of RNase
H(70), peptide sequencing and identi¢cation of the corre-
sponding gene.
3.2. Identi¢cation of the corresponding yeast gene
To obtain the 70 kDa polypeptide for protein sequencing,
C
Fig. 1. Puri¢cation of RNase H(70). A: Puri¢cation scheme; AS,
ammonium sulfate. B: Protein and activity pro¢le of the ¢nal step,
chromatofocusing on Mono P. Proteins from fractions 4^8 from the
Mono P column were separated by 12% SDS-PAGE and silver
stained (left panel, the bands identical in all fractions result from a
staining artifact), as well as analyzed by in situ renaturation gel as-
say (right panel). Protein size markers are indicated between the
two panels.
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the RNase H(70) preparation was processed as described in
Section 2, including preparative SDS-PAGE, concentration
on Vandekerckhove gel, blotting onto nitrocellulose, and
Coomassie brilliant blue R-250 staining. The stained spot
was cut out and digested overnight with trypsin. HPLC puri-
¢cation of the tryptic peptides and Edman sequencing yielded
the following three peptide sequences: TSVQEDDHT,
NTFNEISD, and CVEDDET. Using those sequences, we un-
ambiguously identi¢ed ORF YGR276c as the gene for RNase
H(70) in the S. cerevisiae genome. We therefore renamed this
Fig. 2. Multiple sequence alignment of homologous parts from yeast RNase H(70), and corresponding eukaryotic open reading frames. The
alignment was generated, using the ‘multiple sequence alignment with hierarchical clustering’ method of Corpet [27], and sequences from the S.
cerevisiae ORF YGR276c (553 aa, marked RNase H(70), Swiss-Prot accession number P53331), the GOR antigen of the chimpanzee P. troglo-
dytes (525 aa, partial sequence; EMBL accession number D10017), a C. elegans ORF (594 aa; marked caeno594; GenBank accession number
AF016430), the S. cerevisiae ORF YNL107w (130 aa; EMBL accession number Z73280), the Xenopus laevis XPMC2 protein (421 aa; GenBank
accession number U10185), the S. cerevisiae ORF YO080c (289 aa; GenBank accession number Z74822), a C. elegans ORF (271 aa; marked
caeno271; Swiss-Prot accession number Q101024), and the human ISG20 protein (179 aa; GenBank accession number X89773). Numbering of
amino acids above the alignment corresponds to the consecutive sequence of yeast RNase H(70) (only regions with existing consensus are
shown). Amino acids identical in all sequences are marked in bold letters, and similar amino acids are underlined. In the consensus sequence
(marked consensus), bold letters indicate identical and asterisks similar amino acids. In addition, identities between RNase H(70) and GOR are
marked # in the line ‘gcon’ above the alignment. Parameters used for the alignment: Symbol comparison table: blosum62; gap weight: 12;
gap length weight: 2. Five regions of clustered identical or similar amino acids are indicated as I, II, III, IV, and V below the consensus.
Table 1
Puri¢cation of yeast RNase H(70)
Total protein
(mg)
Protein
(mg/ml)
Speci¢c activity
(U/Wg)
Total activity
(U)
Yield
(%)
Puri¢cation factor
(fold)
Extracta 6396 31.2 137 8.8U108 100 1
DNA cellulose 280 1.6 1 052 2.9U108 34 8
Phenyl-Sepharose 29 0.28 2 260 6.5U107 7.6 16
Hydroxyapatite 2.88 0.16 20 270 5.8U107 6.8 148
A⁄-Gel Blue 0.13 0.003b 309 910 4.0U107 4.7 2 260
Mono P n.d. n.d. n.d. n.d. n.d. n.d.
n.d.: not determined by activity test in solution.
aCell extract after PEG precipitation.
bEstimation by silver staining.
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ORF, which encodes a potential protein of molecular mass
62 849 and which is located on the right arm of chromosome
VII, RNH70. The obvious molecular mass di¡erence between
the putative protein encoded by ORF RNH70 and the isolated
protein might be due to post-translational modi¢cation.
3.3. Sequence comparison uncovers a relationship between yeast
RNase H(70) and other eukaryotic proteins
When searching the non-redundant protein database at
NCBI using the BLAST program, we found highly signi¢cant
homologies of the yeast RNase H(70) with the GOR antigen
of the chimpanzee, Pan troglodytes, with a Caenorhabditis
elegans ORF of 594 aa, with the S. cerevisiae ORFs
YLR107w and YO080c, the Xenopus laevis XPMC2 protein,
a C. elegans ORF of 271 aa, and the human ISG20 protein.
An alignment of these sequences is shown in Fig. 2. Using the
‘multiple sequence alignment with hierarchical clustering’
method of Corpet [27], we detected ¢ve highly conserved mo-
tifs in all of the eight analyzed sequences. Another feature of
the sequence becomes evident using the newly established po-
sition-speci¢c iterated BLAST (PSI-Blast) program [28]. It
indicates that RNase H(70) is additionally related to prokary-
otic DNA polymerases I and III and prokaryotic RNases T
(data not shown).
3.4. Deletion of the gene RNH70 from the genome does not
result in a phenotype easily discernible under laboratory
conditions
Using integrative transformation [26] with the deletion con-
struct described in Section 2, we obtained the viable haploid
strain BC70. A cell extract of this strain exhibited no signi¢-
cant decrease in overall RNase H activity compared to an
extract from the corresponding RNase H(70) pro¢cient strain
(data not shown). RNase H activity was enriched from cell
extracts of both strains by removal of nucleic acids and DNA
cellulose chromatography (see Section 2), and the resulting
fractions were tested for RNase H activity using Mg2 as
divalent cation. Again no signi¢cant change in RNase H ac-
tivity between the fraction derived from the deletion mutant
and that derived from the strain with the intact RNH70 gene
was found. Additional experiments were performed to look
for a mutant phenotype of the deletion strain: there was no
di¡erence in the proliferation rates of the RNase H(70) pro-
¢cient or de¢cient cells as determined at 16‡C, 30‡C and 37‡C
(data not shown).
3.5. RNase H(70) is localized in the nucleus
Considering the enzyme activity and the potential nuclear
localization signals (KKKK at aa 44 or 45, and at aa 178;
KKRR at aa 19; KKPR at aa 462, or KPRK at aa 463) of
RNase H(70), we looked where the enzyme was located within
living cells. For that purpose we employed transformation of
yeast cells with an expression vector containing RNH70 fused
to the gene for the EGFP as described in Section 2. These
experiments, shown in Fig. 3, revealed a £uorescent signal
exclusively in the nucleus (panel A), as was con¢rmed by
co-staining of DNA (panel B). Control experiments using
the expression vector alone showed a uniform distribution
of £uorescence within the cells (not shown).
4. Discussion
In the work presented here, we have reported the puri¢ca-
tion to homogeneity of an enzyme, RNase H(70) of S. cere-
visiae, which we had discovered more than 15 years ago [14].
Several obstacles severely impeded our e¡orts. (i) The poly-
peptide is highly sensitive to proteolysis which results in
breakdown products, some of which retain enzyme activity.
Therefore, only after the ¢nal puri¢cation step could we un-
ambiguously prove enzyme activity in the in situ renaturation
gel assay, and discriminate RNase H(70) from other yeast
RNases H. (ii) RNase H(70) is expressed in only very low
amounts during the whole cell cycle (data not shown). (iii)
During puri¢cation a high proportion of the enzyme is lost
by proteolysis whereas a copurifying polypeptide of similar
molecular mass, the poly(A) binding protein, obviously is
more stable and therefore is enriched in comparison to RNase
H(70). Finally, however, an improved puri¢cation procedure
enabled us to obtain a small amount of enzyme free of im-
purities, which could be used for isolation and sequencing of
several tryptic peptides. Together these peptides were found in
one ORF of the S. cerevisiae genome, namely in YGR276c on
the left arm near the telomere of chromosome VII.
YGR276c, renamed RNH70, encodes a polypeptide of cal-
culated molecular mass 62 849. At present we do not know the
reason for the di¡erence of this molecular mass from the
observed protein band in SDS-PAGE at about 70 kDa; the
di¡erence may be due to post-translational modi¢cations
which have to be elucidated in further studies. During chro-
matofocusing on Mono P a pI of around 5 was observed,
whereas the pI calculated from the amino acid sequence de-
duced from ORF YGR276c is 6.75. Thus, phosphorylation
might be the reason for the acidic pI as well as for the ob-
served molecular weight. Not unexpectedly, RNase H(70)
could be identi¢ed as a nuclear protein.
We were surprised by our result that complete removal of
Fig. 3. Fluorescence microscopy of yeast cells expressing the RNase
H(70)-EGFP fusion protein. Cells of strain AK606 were transfected
with plasmid pUG36-RNH70 carrying the EGFP fusion construct,
¢xed and stained with DAPI. A: Localization of the expressed
EGFP fusion protein. B: Costaining of DNA with DAPI.
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gene RNH70 did not lead to an abnormal phenotype of the
deletion mutants, at least not under the conditions tested.
Recently we had discovered another RNase H of yeast,
RNase H(35) [8]. Deletion of the coding region of that enzyme
also did not entail a severely pathological phenotype but a
signi¢cant decrease of total RNase H activity in the cell ex-
tract of the deletion mutant. Still another yeast gene encoding
a protein with RNase H activity is known, RNH1 [7], the
deletion of which again does not have a dramatic impact on
the a¡ected cells. Strangely enough, even cells harboring com-
bined deletions of the as yet known RNase H genes are viable
(manuscript in preparation). Hence, di¡erent proteins possess-
ing RNase H activity evidently are able to substitute for each
other, and additional such protein(s) must exist in yeast cells.
The only candidate we are at present aware of is Rad27p/
FEN1 [29].
Another remarkable ¢nding is the fact that the amino acid
sequence of neither RNase H(35) nor RNase H(70) of S.
cerevisiae is evolutionarily related to that of the ‘prototype’
RNases H, the RNase HI of E. coli and the RNase H domain
of retroviral reverse transcriptase. Unexpectedly, selective hy-
drolysis of the RNA strand from a RNA-DNA hybrid can be
carried out by polypeptides of completely unrelated primary
structures. A homology search with the yeast RNase H(70)
amino acid sequence revealed the GOR protein as the closest
relative. This chimpanzee (and human) autoimmune antigen
elicits an autoimmune response in a high proportion of hep-
atitis C patients [30]. The currently incurable disease is caused
by the single (+) stranded RNA hepatitis C virus, it has enor-
mous medical impact, as it may ¢nally lead to cirrhosis and/or
hepatocellular carcinoma. Although the complete sequence of
the GOR protein is still unknown we suspect that it may be
the human homolog of S. cerevisiae RNase H(70). In this
connection another vertebrate RNase H should be mentioned:
about 10 years ago a bovine RNase H was described [31]
which resembled yeast RNase H(70) in several respects but
seemed to be di¡erent from bovine RNases HI and II. The
78 kDa protein was, like yeast RNase H(70), shown to be
strongly inhibited by N-ethylmaleimide and to prefer Mg2
over Mn2 as divalent cation. Furthermore it stimulated in
vitro enzyme activity of DNA polymerase K [31]. Whether this
bovine enzyme might be the homolog of yeast RNase H(70),
or even of the so-called GOR protein, remains to be deter-
mined. Another human relative of yeast RNase H(70) is the
interferon stimulated ISG20 protein. Together with PML
(promyelocytic leukemia protein) and SP100 (an autoantigen
of patients su¡ering from biliary cirrhosis), it is found in
nuclear matrix associated multiprotein complexes, the so-
called PML nuclear bodies, which might play a role during
viral infections [32].
A remarkable homolog of RNase H(70) is also protein
XPMC2 of Xenopus laevis, which is able to suppress certain
mutations leading to mitotic catastrophe in the ¢ssion yeast
Schizosaccharomyces pombe [33]. Interestingly, the use of PSI-
Blast homology searches uncovered even sequence parts of
prokaryotic DNA polymerases I and III, and RNases T as
more distant relatives of RNase H(70). We hypothesize that
these related proteins (or protein domains) might comprise a
new superfamily of evolutionarily conserved nucleases.
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